October 28, 2021
Werewolf Therapeutics Appoints Meeta Chatterjee, Ph.D., to its Board of Directors
Over 30 years of broad strategic and operational experience in pharmaceutical research and development, mergers and acquisition evaluation, in-licensing, and externalization activities